The Pivotal Alliance

Evitria is an established, global antibody expression service provider located in Zurich, Switzerland. They specialise in CHO-based transient expression of antibodies (including bispecific and fusion antibodies) and other proteins.

With a track record of more than 80,000 transfections performed and more than 13,000 antibodies/antibody based molecules expressed and purified for their clients from the Americas, Europe, Asia and Australia – ranging from academic laboratories and small biotech start-ups to global biopharmaceutical companies – you can benefit from their expertise when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.